跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BENEFIX factor IX recombinant 3000 IU powder for injection vial and diluent syringe composite pack - TGA Drug Approval Details
Approvals
/
TGA
/
BENEFIX factor IX recombinant 3000 IU powder for injection vial and diluent syringe composite pack
Approved
STANDARD
BENEFIX factor IX recombinant 3000 IU powder for injection vial and diluent syringe composite pack
Pfizer Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
c314b9525ff930c2
Company
Pfizer Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c314b9525ff930c2
Product Name
BENEFIX factor IX recombinant 3000 IU powder for injection vial and diluent syringe composite pack
Artg Id
203316
Artg Name
BENEFIX factor IX recombinant 3000 IU powder for injection vial and diluent syringe composite pack
Sponsor
Pfizer Australia Pty Ltd
Company Detail Path
/organization/pfizer-australia-pty-ltd
Artg Date
2013-08-20
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/28ed7b175a23eb3bf56e005f043926a0.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/6a7637ed1adada34f922923c2f8238eb.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
c314b9525ff930c2
Type
Standard
Back to TGA Approvals